Baptist Health International Conference Series: Past, Present and Future of Genetic Cancer Risk Assessment
Genetic testing can help estimate a people’s chances of developing cancer in their lifetime based on changes and mutations in their genetic pedigree. It is important for physicians to identify appropriate patients to refer for a genetic cancer risk assessment (GCRA). During this conference participants will be able to summarize the benefits and limitations of surveillance and risk management options for cancer predisposition syndromes.
General Surgeons, General Practitioners, Oncologists, Medical Oncologists, Hospitalists, Nurses and all other interested healthcare professionals.
- Identify appropriate patients to refer for a genetic cancer risk assessment (GCRA).
- Explain the GCRA process and recognize the changing landscape of genetic testing – syndrome-driven versus multi-gene panels.
- Summarize the benefits and limitations of surveillance and risk management options for cancer predisposition syndrome.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Clinical Social Workers, Marriage and Family Therapists and Mental Health Counselors
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy